ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Ethnopharmacology
This article is part of the Research TopicHerbal Medicine for the Treatment of Chronic Metabolic Diseases, Volume IIView all 54 articles
Galgeun-tang modulates lipid, glucose, and energy metabolism in diet-induced obesity across cellular, nematode, and murine models
Provisionally accepted
- 1Dongguk University, Jung-gu, Republic of Korea
- 2Dongguk University Gyeongju, Gyeongju, Republic of Korea
- 3Dongguk University Ilsan Hospital, Goyang-si, Republic of Korea
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Galgeun-tang (GGT) is a traditional Korean multi-component formulation composed of several botanical drugs and has long been prescribed for febrile and musculoskeletal disorders. With the global rise in obesity and obesity-related metabolic diseases, there is increasing demand for safer and multi-targeted therapeutic strategies. However, the systemic metabolic effects and anti-obesity potential of GGT remain incompletely understood. Methods: The anti-obesity effects of GGT were evaluated using a tiered experimental approach comprising C2C12 myotubes, high-fat diet (HFD)-induced obese C57BL/6J mice, and Caenorhabditis elegans (C. elegans) exposed to high-glucose conditions. In vitro analyses assessed glucose uptake, gene expression, and protein signaling pathways. In mice, body weight, glucose tolerance, serum biochemical parameters, histological changes, and hepatic and adipose gene expression were examined. In C. elegans, lifespan, lipid and glucose accumulation, and insulin signaling–related gene expression were analyzed following treatment with GGT or metformin (MET). Results: GGT enhanced glucose uptake and increased the expression of insulin-responsive and mitochondrial regulatory genes in C2C12 myotubes. In HFD-fed mice, GGT attenuated body weight gain, improved glucose tolerance and insulin sensitivity, and alleviated hepatic steatosis and adipose hypertrophy, accompanied by suppression of lipogenic genes and induction of β-oxidation markers. In C. elegans, GGT reduced lipid and glucose accumulation, prolonged lifespan, and modulated the expression of insulin signaling–related genes, including daf-16 and daf-2. Across models, GGT exerted metabolic benefits in a dose-and context-dependent manner, with effects comparable to those of MET. Conclusions: GGT improves obesity-related metabolic dysfunction by coordinately regulating glucose homeostasis, lipid metabolism, and energy expenditure across cellular, nematode, and murine models. These findings provide preclinical evidence supporting GGT as a multi-targeted herbal intervention for obesity and metabolic disorders and warrant further targeted mechanistic studies and clinical investigations.
Keywords: Botanical drugs, Caenorhabditis elegans, Energy Metabolism, Galgeun-tang, glucose metabolism, Lipid Metabolism, Obesity
Received: 17 Nov 2025; Accepted: 02 Feb 2026.
Copyright: © 2026 Han, Park, Heo and Kim. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hojun Kim
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.